Christopher S Hourigan

38PUBLICATIONS
229CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyGene expression (incl. microarray and other genome-wide approaches)Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 02, 2026
Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

|Jun 04, 2026
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

|Feb 06, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.

Niveditha Ravindra, Justin Lack, Clifton L Dalgard

|Dec 17, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.

Kai Yu, Laura W Dillon, Jesse M Tettero

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

Pageof 7

Frequent Collaborators

13 joint publications

Laura W Dillon

8 joint publications

Mark R Litzow

7 joint publications

Daniel Weisdorf

7 joint publications

Taiga Nishihori